Survival update in randomized phase II trial of S-1/cisplatin (SP) or docetaxel/cisplatin (DP) with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (NSCLC)-TORG1018
2018 ◽
Vol 29
◽
pp. viii491
◽
Y. Takiguchi
◽
K. Yamada
◽
H. Tanaka
◽
K. Kubota
◽
K. Kishi
◽
...
Tsuneo Shimokawa
◽
Kazuhiko Yamada
◽
Hiroshi Tanaka
◽
Kaoru Kubota
◽
Yuichi Takiguchi
◽
...
G. Teodorescu
◽
T. Ciuleanu
◽
A. Grigorescu
◽
E. Firoiu
◽
D. Ruta Muresan
2012 ◽
Vol 77
(1)
◽
pp. 89-96
◽
Luhua Wang
◽
Shixiu Wu
◽
Guangfei Ou
◽
Nan Bi
◽
Wenfeng Li
◽
...
Kazuya Takamochi
◽
Kenji Suzuki
◽
Masahiro Tsuboi
◽
Seiji Niho
◽
Satoshi Ishikura
◽
...
2010 ◽
Vol 5
(5)
◽
pp. 673-679
◽
Benjamin Movsas
◽
Corey J. Langer
◽
Helen J. Ross
◽
Luhua Wang
◽
Robert M. Jotte
◽
...
2016 ◽
Vol 27
◽
pp. vi412
K. Yamada
◽
T. Shimokawa
◽
H. Okamoto
◽
H. Tanaka
◽
K. Kubota
◽
...
2004 ◽
Vol 10
(15)
◽
pp. 5022-5026
◽
Martin J. Edelman
◽
Joseph I. Clark
◽
Kari Chansky
◽
Kathy Albain
◽
Nirmala Bhoopalam
◽
...
2016 ◽
Vol 77
(3)
◽
pp. 539-548
◽
Su Jin Heo
◽
Inkyung Jung
◽
Choong-kun Lee
◽
Jee Hung Kim
◽
Sun Min Lim
◽
...
2003 ◽
Vol 1
(5)
◽
pp. S235
J. Iglesias
◽
C. Crombie
◽
W.I. Burns
◽
C. Karapetis
◽
R.M. Lowenthal
◽
...
Close
Export Citation Format
Close
Share Document
Close